Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$207.0M
+19.5% from 2023
Prescriptions
15K
$14,250.58 per claim
Patients
2,653
2,481 prescribers
Total spending, 2024
$207.0M
$77,997.38 per patient
Medicare prescription drug plans paid $207.0M for Mekinist in 2024, for 14,525 prescriptions and refills to 2,653 patients (up 19.5% from 2023). The average cost per claim was $14,250.58.
California had the highest Medicare cost for Mekinist in 2024: $29.2M for 2,073 claims, followed by Texas ($17.4M).
Eric J Sherman, medical oncology in Philadelphia, PA, had the highest Medicare cost for Mekinist in 2024: 63 claims costing $1.1M.
Mekinist is made by Novartis AG (NVS), listed in the Medicare spending data as Novartis.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Eric J Sherman Philadelphia, PA | Medical Oncology | 63 | 17 | $1.1M |
| Priyanka C Iyer Houston, TX | Endocrinology | 57 | Under 11 | $881K |
| Nabil F Saba Atlanta, GA |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 2,155 | 12,245 | 2,281 | $159.1M |
| 2023 | 2,210 | 12,290 | 2,285 | $173.2M |
| 2024 | 2,481 | 14,525 | 2,653 | $207.0M |
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Medical Oncology |
| 51 |
| Under 11 |
| $853K |
| Victoria M Villaflor Orange, CA | Medical Oncology | 55 | 12 | $826K |
| Mabel M Ryder Rochester, MN | Endocrinology | 65 | 14 | $793K |
| Ramona Dadu Houston, TX | Endocrinology | 56 | Under 11 | $758K |
| Maria E Cabanillas Houston, TX | Endocrinology | 49 | 12 | $715K |
| Michael M Buljan San Francisco, CA | Nurse Practitioner | 52 | Under 11 | $670K |
| James W Smithy New York, NY | Medical Oncology | 35 | Under 11 | $637K |
| Siddharth H Sheth Pittsburgh, PA | Internal Medicine | 46 | Under 11 | $583K |
| Parisa Momtaz West Harrison, NY | Hematology-Oncology | 31 | Under 11 | $566K |
| Kristen M Burkett Westwood, KS | Nurse Practitioner | 38 | Under 11 | $559K |
| Ahmed M Abdelaziz Tucson, AZ | Hematology-Oncology | 32 | Under 11 | $526K |
| Naifa L Busaidy Houston, TX | Endocrinology | 35 | Under 11 | $524K |
| Meetal Dharia Los Angeles, CA | Nurse Practitioner | 30 | Under 11 | $495K |
| Gary C Doolittle Westwood, KS | Medical Oncology | 32 | Under 11 | $482K |
| Sandeep H Mashru Portland, OR | Hematology-Oncology | 33 | Under 11 | $468K |
| Kin Wai Hung Hartford, CT | Medical Oncology | 28 | Under 11 | $467K |
| David E Marinier La Crosse, WI | Hematology-Oncology | 35 | Under 11 | $466K |
| Kathleen C Kerrigan Columbus, OH | Hematology-Oncology | 30 | Under 11 | $462K |
| Conor E Steuer Atlanta, GA | Hematology-Oncology | 28 | Under 11 | $429K |
| Arvinda Padmanabhan Lexington, KY | Medical Oncology | 28 | Under 11 | $427K |
| Anupam M Desai Boston, MA | Hematology-Oncology | 27 | Under 11 | $426K |
| Kenneth B Ain Lexington, KY | Endocrinology | 26 | Under 11 | $425K |
| Mimi I Hu Houston, TX | Endocrinology | 28 | Under 11 | $422K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Novartis NVS | 14,526 | $207.0M |